BACAMID 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, Alu-Alu blister pack

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

lamivudine, Quantity: 300 mg; abacavir sulfate, Quantity: 702.762 mg (Equivalent: abacavir, Qty 600 mg)

Prieinama:

Hetero Australia Pty Ltd

Vaisto forma:

Tablet

Sudėtis:

Excipient Ingredients: microcrystalline cellulose; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow FCF; polysorbate 80; macrogol 400

Vartojimo būdas:

Oral

Vienetai pakuotėje:

30's

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

BACAMID 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). BACAMID 600/300 is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age.

Produkto santrauka:

Visual Identification: Orange modified capsule shaped, biconvex film-coated tablets debossed with 'H' on one side and 'A1' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorizacija statusas:

Registered

Leidimo data:

2022-12-13

Pakuotės lapelis

BACAMID 600/300/07112018/V2
1
BACAMID 600/300 TABLETS
_abacavir (as sulfate) and lamivudine_
CONSUMER MEDICINE INFORMATION
PATIENTS TAKING BACAMID 600/300, WHICH CONTAINS ABACAVIR, MAY DEVELOP
A
HYPERSENSITIVITY
REACTION (SERIOUS ALLERGIC REACTION) WHICH CAN BE LIFE-THREATENING IF
TREATMENT
WITH BACAMID 600/300 IS CONTINUED. CONTACT YOUR DOCTOR IMMEDIATELY FOR
ADVICE ON
WHETHER YOU SHOULD STOP TAKING BACAMID 600/300 IF:
1)
YOU GET A SKIN RASH OR
2)
YOU GET ONE OR MORE SYMPTOMS FROM AT LEAST TWO OF THE FOLLOWING
GROUPS:
-
FEVER
-
SHORTNESS OF BREATH, SORE THROAT OR COUGH
-
NAUSEA OR VOMITING OR DIARRHOEA OR ABDOMINAL PAIN
-
SEVERE TIREDNESS OR ACHINESS OR GENERALLY ILL FEELING
IF YOU HAVE HAD A HYPERSENSITIVITY (ALLERGIC) REACTION TO BACAMID
600/300 TABLETS,
NEVER TAKE
BACAMID 600/300, OR ANY OTHER MEDICINAL PRODUCT CONTAINING ABACAVIR
(KIVEXA, TRIUMEQ,
TRIZIVIR &
ZIAGEN) AGAIN AS YOU MAY DEVELOP A LIFE THREATENING REACTION WHICH CAN
BE FATAL.
THERE IS AN ALERT CARD INCLUDED IN THE BACAMID 600/300 PACK, TO REMIND
YOU AND MEDICAL
STAFF ABOUT ABACAVIR HYPERSENSITIVITY. THIS CARD SHOULD BE REMOVED
FROM THE PACK
AND KEPT WITH YOU AT ALL TIMES. SEE MORE DETAILS UNDER BEFORE YOU TAKE
BACAMID
600/300.
BACAMID 600/300/07112018/V2
2
WHAT IS IN THIS LEAFLET?
Please read this leaflet carefully
before you start BACAMID 600/300
tablets.
This leaflet answers some common
questions about BACAMID 600/300
tablets. It does not contain all of the
available information.
It does not take the place of talking
to your doctor or pharmacist (also
known as a chemist).
All medicines have benefits and
risks. Your doctor has weighed the
expected benefits of you taking
BACAMID 600/300 tablets against
the risks this medicine could have for
you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE TABLETS.
You may need to read it again.
WHAT BACAMID
600/300 TABLETS ARE
USED FOR
BACAMID 600/300 tablets contain
abacavir and lamivudine which
belong to a group of medicines
called antiretrovira